Inside the billion-dollar meeting for the mega-rich who want to live forever
By Jessica Hamzelou,
MIT Technology Review
| 11. 16. 2022
“Who wants to live forever?” The immortal words of Freddie Mercury blast from the speakers as blue lights swivel around the room and a smoky mist floats up from the stage in front of me. If the audience is anything to go by, the answer to his question is: the mega rich.
I’d come to Gstaad, a swanky ski-resort town in the Swiss Alps, to attend the first in-person Longevity Investors Conference. Over the two-day event, scientists and biotech founders made the case for various approaches to prolonging the number of years we might spend in good health. And the majority of them were trying to win over deep-pocketed investors.
There were 150 people at this meeting, and its organizers told me that 120 of them were investors with millions or even billions of dollars at their disposal—and at least a million dollars ready to pump into a longevity project. Plenty of would-be attendees were denied a $4,500 ticket because they didn’t meet this criterion, an event co-organizer tells me.
The conference was unlike any academic meeting I’ve ever attended...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...